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Abstract
Cocaine administered chronically throughout gestation has been correlated with deficits in
maternal behavior, increased maternal aggressive behavior and decreased oxytocin levels in rats.
In addition to its effects on oxytocin levels, cocaine is a potent serotonergic, dopaminergic and
noradrenergic reuptake inhibitor. Alterations in the dopaminergic and serotonergic systems have
been suggested as possibly having a role in cocaine-induced maternal aggression. This study was
in part, an attempt to understand some of the mechanisms by which cocaine increases postpartum
aggression, particularly as they relate to changes in the oxytocin system.
Oxytocin receptor number and binding affinity in the medial preoptic area of the hypothalamus,
ventral tegmental area, hippocampus and amygdala were determined for lactating rat dams on
postpartum day 6 (PPD 6) that were gestationally treated with cocaine, fluoxetine, saline or an
amfonelic acid/fluoxetine drug combination. Cocaine and fluoxetine treatment both resulted in a
significant up-regulation of oxytocin receptor number and lower receptor affinity in the amygdala
of lactating rat dams compared to saline controls and the amfonelic acid/fluoxetine combination
treatment group. Cocaine treatment also resulted in a significant down-regulation of oxytocin
receptors in the medial preoptic area and both cocaine and fluoxetine treated dams had the highest
affinity for oxytocin receptors in this brain region. Results of the present study support previous
data indicating that alterations in oxytocinergic and perhaps serotonergic system dynamics in the
amygdala may play a role in cocaine-induced postpartum aggression.
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1. Introduction
A growing body of literature demonstrates that cocaine given chronically to rats throughout
gestation is associated with decreased levels of the neuropeptide oxytocin (OT) (Johns et al.,
1995, 1997, 1998; Elliott et al., 2001) in brain structures implicated in maternal behavior
and/or maternal aggressive behavior, including the Medial pre-optic area (MPOA) of the
hypothalamus (Pedersen et al., 1994), ventral tegmental area (VTA) (Numan and Smith,
1984), hippocampus (Kimble et al., 1967), and amygdala (Fleming et al., 1980; Lubin et al.,
2003b). Furthermore, cocaine-induced disruptions in the onset of maternal behavior (Heyser
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et al., 1992; Zimmerberg and Gray, 1992; Johns et al., 1994; Kinsley et al., 1994; Vernotica
et al., 1996) have been correlated with decreased OT levels in the MPOA, VTA and
hippocampus (Johns et al., 1997). Cocaine-induced decreases in OT levels in the amygdala
have also been associated with heightened postpartum aggression towards intruders (Johns
et al., 1995, 1998).
Direct antagonism of OT activity in the VTA and MPOA has produced disruptions in
maternal behavior onset in rats (Pedersen et al., 1994). More recently, blockade of OT
activity in the paraventricular nucleus of the hypothalamus (Giovenardi et al., 1997, 1998)
and the amygdala (Lubin et al., 2003b) has been correlated with increased maternal
aggressive behavior in the lactating rat. Therefore, both cocaine-induced decreases in OT
levels and direct antagonism of OT activity in relevant brain areas have been associated with
altered maternal behavior and maternal aggressive behavior. In the search for mechanisms
that may underlie cocaine’s effects on OT and subsequent postpartum aggressive behavior,
there is some evidence that cocaine-induced changes in the dynamics of both the
serotonergic (5-HT) and/or dopaminergic (DA) systems could play a role (Lubin et al.,
2003a). Cocaine, a central nervous system stimulant and DA, 5-HT and noradrenergic (NE)
uptake inhibitor, appears to have an antagonistic relationship with OT (Kovacs et al., 1990;
Sarnyai et al., 1991). Both affect common brain structures or pathways involved in maternal
behavior or maternal aggression. In addition to having OT neurons, fibers and/or receptors,
the paraventricular nucleus, hippocampus, amygdala, MPOA and VTA contain DA, 5-HT
and NE projections, neurons or receptors (Kimble et al., 1967; Fahrbach et al., 1985;
Kendrick et al., 1987; Tribollet et al., 1988; Burt, 1993; Numan, 1994; Pedersen et al.,
1994). There is anatomical evidence that OT neurons are in close contact or have synaptic
connections with axons of neurons of these three neurotransmitter systems (Burt et al., 1993;
Horie et al., 1993) and that OT system dynamics (release, levels or receptors) can be altered
by both cocaine and by manipulation of each of the aforementioned neurotransmitter
systems (Rosenberg et al., 1977; Honda et al., 1985; Drago et al., 1986; Giordano et al.,
1990; Kovacs et al., 1990; Cunningham et al., 1992; Kendrick et al., 1992; Sarnyai et al.,
1992; Hansen, 1994; Van de Kar et al., 1995; Bagdy, 1996; Thomas and Palmiter, 1997; Ji
et al., 1998; Onaka and Yagi, 1998). While there is almost no evidence for NE being
involved in maternal aggression (Sorenson and Gordon, 1975), both DA and 5-HT systems
are implicated as possible systems underlying aggressive behavior (Neckers et al., 1975; Ieni
and Thurmond, 1985; Mos et al., 1990; Olivier and Mos, 1992; De Almeida and Lucion,
1994; Moeller et al., 1994; Olivier et al., 1995; Matto et al., 1998). In preliminary studies
(Johns et al., 1995; Lomas et al., 2002), there were reported decreases or increases
respectively in OT levels in the amygdala of rats treated during gestation with 5-HT or DA
reuptake inhibitors. However, there is no available data evaluating the potential
compensatory effects following administration of cocaine or by manipulation of either or a
combination of these neurotransmitter systems during gestation on oxytocin receptors in
relevant brain structures other than a very preliminary study with cocaine alone (Johns et al.,
1999). Fluoxetine, a selective 5-HT uptake inhibitor, has a half-life of approximately 8–15 h
(including its metabolites) in rats (Raap and Van de Kar, 1999) and has been successfully
administered to pregnant rats (Montero et al., 1990). While FLU is selective to the 5-HT
system, it is not selective to one specific receptor subtype and it is similar to cocaine in that
it causes minor anorexia in rats and has been used in a previous behavioral study of maternal
aggressive behavior (Lomas et al., 2002).
Amfonelic acid (AFA), a selective dopamine uptake inhibitor, at moderate doses, like
cocaine is a non-amphetamine stimulant that has few effects on the noradrenergic system
and has been described as very selective in vivo for protecting DA storage pool content
(Fuller and Perry, 1981). AFA has been shown to cause enhancement of extrapyramidal
dynorphin-like immunoreactivity similar to that shown with cocaine administration which is
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thought to result primarily from the ability of cocaine to block DA uptake (Smiley et al.,
1990). AFA produces significant DA uptake blockade for about 12 h after injection (half life
8–12 h) and produces behavioral hyperactivity and stereo-typies similar to 30 mg/kg of
cocaine. While gestational treatment with AFA alone seems to decrease maternal aggression
(Johns et al., 1995), it was thought that when given in combination with a sertonergic
reuptake inhibitor, it may produce different results. Therefore, the present study examined
the effects of gestational treatment with cocaine, fluoxetine (FLU), a combination treatment
of FLU and amfonelic acid (AFA) or saline administration on OT receptor dynamics in
brain areas implicated in maternal behavior and/or maternal aggression.
2. Methods
2.1. Animals
Virgin female Sprague–Dawley rats (200–225 g) were group housed in a temperature and
humidity controlled room for a one-week habituation period prior to mating. Females were
then singly housed with a sexually active male until conception was noted by the presence of
a sperm plug and confirmation by a vaginal smear, if necessary. On the day a sperm plug
was present, gestation day 0, the female was removed from the breeding cage, assigned to
one of four treatment groups, and individually housed. Singly housed pregnant females were
maintained on a reversed 12 h:12 h light cycle (with lights off at 09:00 h) for 8 days, then
transferred to a room with a regular light cycle (lights on at 07:00 h) for the remainder of the
experiment. This procedure generally results in the majority of dams delivering their litters
during daylight hours (Mayer and Rosenblatt, 1998). All females except the saline-treated
dams were allowed ad libitum access to food (Purina Rat Chow) and water throughout the
experiment. Since both cocaine and fluoxetine have anorectic properties, the saline control
group was yoked or pair-fed to the cocaine-treated dams such that they were only allowed
access to as much food on any particular gestation day as the average amount of food
consumed by cocaine-treated dams on that same gestation day.
2.2. Treatment
Ninety-six pregnant females (24 females/group) were assigned to one of four treatment
groups, cocaine, FLU, an amfonelic acid/fluoxetine (AFA/FLU) combination group and a
saline control group. All dams were injected with their respective treatments or saline
throughout gestation (gestation days 1–20), subcutaneously, twice daily at approximately
9:00 a.m. and 4:00 p.m. as described below. As skin lesions are prone to develop following
repeated subcutaneous administration of cocaine, injection sites for all groups were varied
and drug injections were given on alternating flanks in the morning and afternoon. Any skin
lesions that developed were cleaned with a Betadine wash and a treated with a topical
antibacterial ointment (Polymycin–Bacitracin–Neomycin, Burroughs Wellcome, Raleigh,
NC) as soon as they were discovered. Cocaine-treated females were injected with 15 mg/kg
of cocaine hydrochloride (dose calculated as the free base; Sigma Chemical Company, St.
Louis, MO) dissolved in 0.9% normal saline, for a total daily dose of 30 mg/kg in a total
volume of 2 ml/kg. Saline-treated females were injected with 0.9% (normal) saline (2 ml/kg
total volume).
FLU-treated dams were injected once at 9:00 am with fluoxetine hydrochloride (dose
calculated as the free base; Sigma Chemical Company, St. Louis, MO) dissolved in distilled
water at a concentration of 8 mg/kg and with normal saline at 4:00 p.m. each day. Since no
single drug had the combined 5-HT and DA reuptake inhibition properties that we were
interested in, a combined AFA/FLU treatment group was used in the present study. The
AFA/Flu group received daily injections of 2.5 mg/kg of amfonelic acid (Sigma Chemical
Company, St. Louis, MO) in a pH 10 solution (mixed in 0.1 ml 1N NaOH and 0.6 ml of
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0.1N HCl dissolved in distilled water) on one rear flank and 8 mg/kg of FLU on the other
flank at 9:00 a.m. and an injection of normal saline at 4:00 p.m. AFA/FLU and FLU
injections were given only once daily because of their longer half-life compared to cocaine.
Cocaine, FLU and AFA were stored in amber bottles and the cocaine and saline solution
was maintained in a standard refrigerator when not in use. New solutions of cocaine and
FLU were prepared every three days while AFA was prepared daily.
Immediately following delivery of their last pup, maternal weight, number and sex of the
pups, as well as litter weight was recorded for each dam. Surrogate litters of eight males that
were delivered within 12 h of treatment litter birth were then placed with the rat dams and
remained with her until postpartum day 6 (PPD 6), when dams were killed. The culled litter
size and sex was selected based on previous investigations documenting that this size litter
was more than adequate to maintain maternal behavior (Zimmerberg and Gray, 1992;
Vernotica et al., 1996; Vernotica and Morrell, 1998) and because all male litters have been
previously used for aggression testing (Johns et al., 1994).
2.3. Brain dissections
Dams were decapitated between 10:00 and 12:00 a.m. and the whole hippocampus,
amygdala, VTA, and MPOA brain regions were dissected on ice. Brains were coronally
sectioned from the ventral side rostral to the optic chiasm [approximately A7100 according
to Konig and Klippel (1963) and just caudal to the optic chiasm (approximately A5800) to
define the preoptic-anterior hypothalamic area]. The MPOA was dissected by making a
horizontal cut ventral to the anterior commisure and vertical cuts inferior to the lines of
lateral ventricles. The brains were sectioned once again just caudal to the tuber cinereum
(approximately A3800) to define the medial basal hypothalamus. The amygdala was
removed from these two sections. The whole hippocampus was then removed from the
caudal remainder of the brain, and the VTA dissected from this portion by making dorso-
ventral cuts medial to the optic tracts with a dorsal cut at the ventral extent of the central
gray. Following dissection, brain sections were weighed, rapidly frozen, and stored at −70
°C for subsequent binding assay.
2.4. Plasma membrane preparation
Brain region samples from eight animals per group were combined to have sufficient tissue
to assay an eleven-point saturation curve. Each curve was repeated three times. The pooled
brain samples were homogenized in 19 vol. of cold 0.32 M sucrose containing 1 mM EDTA
in 40 mM Tris–HCl, pH 7.4. The homogenate was centrifuged at 3000 × g for 10 min., and
the supernatent was spun at 48,000 × g for 15 min. The pellet was resuspended in 40 mM
Tris–HCl, pH 7.4, and recentrifuged (48,000 × g for 15 min). The final plasma membrane
pellet was resuspended in assay buffer (40 mM Tris–HCl, pH 7.4, 1 mg/ml BSA and 10 mM
MnCl2) at a protein concentration of approximately 200 μg/100 μl).
2.5. 125I-OTA saturation binding
Oxytocin receptor binding was measured in rat brain plasma membranes using 125I-OTA,
[d(CH2)5, O-Me-Tyr2, Thr4, Tyr9, Orn8]-vasotocin (OTA) (New England Nuclear, Boston
MA). Saturation binding incubations were initiated by adding the membrane preparation to
assay buffer containing eleven concentrations of 125I-OTA (0.05–3 nM) in a final volume of
200 μl in a 96-well Type B Glass Fiber filter plate for the Millipore MultiScreen system.
After a 2 h incubation at 22 °C, the samples were vacuum filtered and rapidly washed with 2
vol. of 200 μl of cold assay buffer to separate bound and free radioligand. Non-specific
binding was determined with a 1000-fold excess of unlabelled oxytocin. Filters were dried
and counted in a LKB CliniGamma counter. Saturation binding data was analyzed using the
iterative curve-fitting program PRISM by GraphPAD (San Diego, CA) to determine the
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binding parameters, receptor number (Bmax) and receptor affinity (KD), in each brain region
for each treatment group.
2.6. Data analysis
Receptor number and affinity, as determined by 125I-OTA binding, were analyzed using an
analyses of variance to compare values for treatment groups followed by Tukey’s HSD for
post-hoc comparisons of significant main effects. Gestational variables were analyzed using
a one-way analyses followed by Tukey’s HSD for post-hoc comparisons of significant main
effects. Mean and standard error of the mean values and probability levels are presented in
tables or text when appropriate. A probability level of P ≤ 0.05 was established as the
significance level for rejection of the null hypothesis. The higher the mean value for Bmax,




There were no significant treatment related differences in the number of live or dead pups,
number of male versus female pups, or litter weight among groups (data not shown). FLU
treated dams gained more weight (157.67 ±4.37) over gestation than did the AFA/FLU dams
(134.45 ± 4.47; P < 0.01). FLU-treated dams also had a trend for a slightly longer gestation
length than other dams (data not shown).
3.2. OT receptor dynamics
3.2.1. Receptor number (Bmax)—The results of the saturation binding data demonstrate
significant changes in receptor number (Bmax) in the amygdala and MPOA. As summarized
in Table 1, there was an up-regulation of 125I-OTA receptor number in the amygdala of the
cocaine and FLU treatment groups compared to saline (P < 0.01). In the combined AFA/
FLU treatment subjects, the addition of AFA counteracted this up-regulation such that the
Bmax in the AFA/Flu group was significantly lower than both the FLU and cocaine-treated
groups (Fig. 1).
These trends were reversed in the MPOA. OT receptors (OTR) in cocaine-treated animals
were significantly down-regulated (P < 0.02) compared to saline controls (Fig. 2, cocaine
and saline groups only represented). The FLU treatment group also showed less binding
than did saline controls (ns), but the AFA/Flu treatment group did not exhibit this decrease.
The hippocampal data was similar in pattern to the MPOA though differences were not
significantly different. The VTA had lower binding overall and no significant differences
between groups were evident.
3.2.2. Receptor affinity (KD)—As shown in Table 2, cocaine and FLU treated subjects
had lower OT receptor affinity in the amygdala. The FLU group exhibited significantly
lower affinity than both saline and AFA/FLU treatment groups (P < 0.01), while affinity in
the cocaine-treated group was significantly lower only than the AFA/Flu treatment (P <
0.01). The cocaine treated rats in particular and FLU subjects less so, had strong trends
indicative of higher receptor affinity compared to control and AFA/FLU treated groups in
the MPOA and hippocampal regions.
4. Discussion
This is the first report of which we are aware that indicates there are both FLU and cocaine-
induced alterations in the number and affinity of OTRs for the highly selective, high affinity
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ligand 125I-OTA (Elands et al., 1987) in the amygdala and MPOA (cocaine only) in lactating
rats on PPD 6. OTR up-regulation in the amygdala was predicted for the cocaine-treated and
FLU-treated dams given previously described oxytocin level reductions found on PPD 6
following this treatment regimen (Johns et al., 1998; Lomas et al., 2002). When there is
rapid binding with slow dissociation then a ligand is thought to have greater affinity for a
receptor. One might expect a greater biological effect when ligands show a higher affinity
for a receptor since they would bind more receptors within a particular time period as
opposed to when receptors show lower affinity and thus less binding for a particular ligand.
The lower OTR affinity found following cocaine and fluoxetine treatments may indicate that
even though there is an up-regulation in receptor number, the lower affinity for these
receptors might reduce the overall biological effect that up-regulation could have. It is
unclear exactly what the treatments do to change the binding affinity and this will be
explored in future studies. The addition of AFA to FLU in the AFA/FLU treatment appears
to offset the effects of FLU alone on OTR dynamics. While this magnitude of effect
following the combination treatment was not predicted, it supports preliminary data from
our lab indicating that treatment with a DA reuptake inhibitor increases OT levels in the
amygdala during the postpartum period (Johns et al., 1995).
Generally increased 5-HT activity is related to decreased aggressive behavior in rodents and
other animals (De Almeida and Lucion, 1994; Olivier et al., 1985; Olivier and Mos, 1992,
1995). It is unclear at this point what the functional effects of this gestational cocaine
regimen are on the 5-HT system. In a recent report (Lubin et al., 2003a) there was a slight
increase in levels of 5-HT in the amygdala on PPD 6 following a dose and regimen similar
to the one used in the present study. This data might indicate that the effects we have seen
on aggression following chronic cocaine treatment are, as we suspect primarily mediated by
OT, but that cocaine-induced alterations of the 5-HT system might have secondary effects
on the OT system.
One of the more interesting results was how closely FLU treatment parallels the effects of
cocaine on OTR number and affinity in the amygdala compared to AFA/FLU treatment.
Had we used an AFA treatment alone we would have predicted the effects we saw in the
AFA/FLU treatment group given that in a previous study, AFA treatment with the dose used
in the present study resulted in higher levels of OT in the amygdala than controls (PPD 8)
and lower aggression on PPD 6 (Johns et al., 1995). Pedersen et al. (1994) found no
significant differences in OTR Bmax or affinity in the amygdala among untreated dams
sacrificed during mid-parturition versus those killed between postpartum days 5 and 7.
Therefore, the changes in amygdaloidal OTRs in cocaine and FLU-treated groups on PPD 6
in the current investigation appear to be treatment dependent.
It is unclear how or if DA or 5-HT regulates release of OT in the amygdala, although the
paraventricular nucleus, which is the main site for OT synthesis and projection, receives
inhibitory 5-HT and DA inputs to the magnocellular OT neurons and these inhibitory
systems are activated under stressful conditions such as might occur when faced with an
intruder (Honda et al., 1985; Burt, 1993). How much effect these inhibitory systems may
ultimately have is questionable given that chronic cocaine administration has been shown to
decrease 5-HT’s regulation of neuroendocrine responses, including the release of OT (Levy
et al., 1992). A number of 5-HT agonists can stimulate peripheral OT release (Bagdy, 1996;
Saydoff et al., 1991; Uvnas-Moberg et al., 1996), and D1 receptor agonists stimulate while
D2 receptor agonists can inhibit OT release (Crowley et al., 1991). It has also been
demonstrated that administration of OT alters monoamine concentrations in various brain
regions (Pfister and Muir, 1989). Future studies manipulating these neurotransmitter systems
may prove valuable in an attempt to discern how they are interacting with OT following
cocaine administration.
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In the present study, there was actually a significant down-regulation of OT receptors in the
MPOA (cocaine only) and non-significant trends toward down-regulation of OTRs in the
hippocampus and VTA of cocaine and FLU treated dams. Since cocaine-induced alterations
in OT levels were not previously found in the VTA or MPOA on PPD 6 (Johns et al., 1997,
1998), clearly the down-regulation in the MPOA does not follow level changes and in fact
data from both the present and previous studies indicate that OTRs may be resistant to
cocaine-induced alterations of levels in some brain regions. The putative lack of consistency
of OTR regulation with level alterations in various brain regions on PPD 6 may simply
corroborate Insel’s (1992) findings that OT poorly regulates OTRs though it is quite likely
that OT activity modulates OTRs in certain circumstances. Engstrøm et al. (1999)
demonstrated that an OT antagonist significantly decreased Bmax without altering the
affinity of OTRs in rat myometrium [the same type of OTR as in brain (Breton and Zingg,
1997)] during labor, when there is normally a significant increase in OTR number
(Engstrøm et al., 1999). In addition, OT increased the affinity of OTRs in the MPOA and
medial basal hypothalamus by converting low affinity sites to high affinity sites, in vitro,
within 30 min of a 2 nM OT exposure (Walker, personal communication, December 2004).
The current investigation did not examine whether there were cocaine-or FLU induced
alterations in transcription or translation of OTRs, or the integrity of the post-synaptic
signaling cascade (including altered G-protein coupling, the phosphoinositol calcium signal
transduction pathway, or subsequent cytosolic calcium concentrations (Barberis et al.,
1998). Ivell and Walther (1999) note that there is a role for indirect regulation of OT and
OTRs either via activation of various intermediaries that ultimately activate the genes, or
through direct activation of steroid receptors on the relevant cell membranes. It is quite
possible given this data that 5-HT receptor activation may be directly regulating OTR
activity independently of OT or other mechanisms and there are 5-HT receptors as well as
OTR located in the MPOA and amygdala. The effects of cocaine and FLU treatment on OT
mRNA are now being investigated in our laboratory.
This study was one in a series of studies recently undertaken to examine possible
mechanisms underlying cocaine-induced alterations in oxytocin system dynamics and to
further examine the hypothesis that cocaine induced alterations in postpartum aggression in
rats are related to changes in the OT system in the amygdala. If indeed, cocaine does alter
postpartum aggression primarily through its effects on the OT system it may do so either
directly or perhaps indirectly acting through one or a combination of the neurotransmitter
systems it affects. In conclusion, OTR number and binding affinity in the amygdala were
altered by both cocaine and FLU in the expected direction. The combination treatment of
AFA/FLU resulted in control levels of OTR binding and affinity suggesting perhaps a lesser
role for the DA system in cocaine-induced levels of post-partum aggression though its
effects are interesting and require further characterization. This study therefore provides
additional, albeit indirect, evidence that cocaine-induced decreases in OT levels and lower
receptor affinity in the amygdala may play a role in increased postpartum aggressive
behavior in rat dams and that 5-HT reuptake inhibition (at the dose used in this study)
produces effects similar to cocaine on OT receptor system dynamics in the amygdala on
PPD 6 and may play some role in the effect of gestational cocaine treatment on postpartum
aggression in the rat.
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125I-OTA saturation binding curves in the amygdala represented by scatchard plots for
cocaine, fluoxetine (FLU), amfonelic acid/fluoxetine (AFA/FLU) and saline treated groups
on postpartum day 6. Lines are composites of three determinations for each treatment. Bmax
and KD data are given in Tables 1 and 2. The cocaine and fluoxetine groups displayed an up-
regulation of receptor binding (Bmax) compared to the saline treated group (P < 0.01) and
lower binding affinity (KD) compared to the AFA/FLU combination (P > 0.01, cocaine and
fluoxetine) and saline treatment groups (P < 0.01, fluoxetine only).
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125I-OTA saturation binding curves in the MPOA represented by scatchard plots. Lines are
composites of three determinations for cocaine and saline treated groups (fluoxetine and
amfonelic acid/fluoxetine not represented) on postpartum day 6. Cocaine treatment resulted
in a significant down-regulation of receptor binding (P < 0.02) compared to saline-treated
controls. Bmax and KD data are given in Tables 1 and 2.
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